vimarsana.com
Home
Live Updates
GenFleet Therapeutics Announces GFH009 Granted with FDA Fast
GenFleet Therapeutics Announces GFH009 Granted with FDA Fast
GenFleet Therapeutics Announces GFH009 Granted with FDA Fast Track, Orphan Drug Designations for Treating R/R Peripheral T-cell Lymphomas and Acute Myeloid Leukemia
SHANGHAI - GenFleet Therapeutics, a clinical-stage biotechnology company developing cutting-edge therapies in oncology and immunology, announced that U.S. Food and Drug Administration has recently...
Related Keywords
Taiwan ,
United States ,
Macau ,
China ,
Shanghai ,
Hong Kong ,
Yu Wang ,
Henan ,
American ,
Chinese ,
,
American Society Of Hematology ,
Sellas Life Sciences ,
Drug Administration ,
Life Sciences Group Nasdaq ,
Fleet Therapeutics ,
Chief Medical Officer ,
Track Designation ,
Accelerated Approval ,
Priority Review ,
Sciences Group ,
News Publishing ,
Markets ,